Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus | Zendy

Qiulan Huang | Zendy; Yanting Huang | Zendy; Jianping Liu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus

Author(s) -

Qiulan Huang,

Yanting Huang,

Jianping Liu

Publication year - 2021

Publication title -

international journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.875

H-Index - 60

eISSN - 1687-8345

pISSN - 1687-8337

DOI - 10.1155/2021/9938658

Subject(s) - medicine , mesenchymal stem cell , diabetes mellitus , stem cell , stem cell therapy , insulin , cell therapy , bioinformatics , cancer research , endocrinology , microbiology and biotechnology , pathology , biology

Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged cells, exerting anti-inflammatory responses and producing immunoregulatory effects that can be significantly induced into insulin-producing cells (IPCs), providing an inexhaustible supply of functional β cells for cell replacement therapy and disease modeling for diabetes. MSC therapy may be the most promising strategy for diabetes mellitus because of these significant merits. In this paper, we focused on MSC therapy for diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research